Brief Summary
Type:
Multiple Sites (Solid Tumors)
Study Type:
Treatment
Phase:
I/II
ClinicalTrials.gov Identifier:
NCT05286801
Study #:
CMH - PEPN2121
Start Date:
Oct 27, 2022
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT05286801
View Complete Trial Details & Eligibility at ClinicalTrials.gov
